FBRX – Forte Biosciences Inc
Forte Biosciences, Inc.FBRX
$7.34Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $48,309,460.00
EPSttm : -12.17
Forte Biosciences, Inc.
$7.34
1.10%$0.08Float Short %
2.22
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
8.57
EPS This/Next Y
1.35
Price
7.34
Target Price
49.33
Analyst Recom
1
Performance Q
-53.54
Relative Volume
0.47
Beta
2.76
Ticker: FBRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | FBRX | 7.34 | N/A | N/A | 0 |
| 2025-03-21 | FBRX | 8.29 | N/A | N/A | 0 |
| 2025-03-24 | FBRX | 6.14 | N/A | N/A | 0 |
| 2025-03-25 | FBRX | 8.5 | N/A | N/A | 0 |
| 2025-03-26 | FBRX | 8.33 | N/A | N/A | 0 |
| 2025-03-27 | FBRX | 7.85 | N/A | N/A | 0 |
| 2025-03-28 | FBRX | 8.24 | N/A | N/A | 0 |
| 2025-03-31 | FBRX | 8.2 | N/A | N/A | 0 |
| 2025-04-01 | FBRX | 7.43 | N/A | N/A | 0 |
| 2025-04-02 | FBRX | 7.35 | N/A | N/A | 0 |
| 2025-04-03 | FBRX | 6.4 | N/A | N/A | 0 |
| 2025-04-04 | FBRX | 6 | N/A | N/A | 0 |
| 2025-04-07 | FBRX | 5.36 | N/A | N/A | 0 |
| 2025-04-08 | FBRX | 5.53 | N/A | N/A | 0 |
| 2025-04-09 | FBRX | 5.53 | N/A | N/A | 0 |
| 2025-04-10 | FBRX | 5.46 | N/A | N/A | 0 |
| 2025-04-11 | FBRX | 5.25 | N/A | N/A | 0 |
| 2025-04-14 | FBRX | 5.58 | N/A | N/A | 0 |
| 2025-04-15 | FBRX | 5.84 | N/A | N/A | 0 |
| 2025-04-16 | FBRX | 7.3 | N/A | N/A | 0 |
| 2025-04-17 | FBRX | 6.81 | N/A | N/A | 0 |
| 2025-04-18 | FBRX | 7.34 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | FBRX | 7.54 | -136.0 | - | -14.81 |
| 2025-03-21 | FBRX | 8.72 | -136.0 | - | -14.81 |
| 2025-03-24 | FBRX | 6.32 | -136.0 | - | -14.81 |
| 2025-03-25 | FBRX | 8.51 | -136.0 | - | -14.81 |
| 2025-03-26 | FBRX | 8.20 | -136.0 | - | -14.81 |
| 2025-03-27 | FBRX | 7.95 | -136.0 | - | -14.81 |
| 2025-03-28 | FBRX | 8.20 | -136.0 | - | -14.81 |
| 2025-03-31 | FBRX | 7.76 | -136.0 | - | -14.81 |
| 2025-04-01 | FBRX | 7.43 | -136.0 | - | -14.81 |
| 2025-04-02 | FBRX | 7.35 | -136.0 | - | -14.81 |
| 2025-04-03 | FBRX | 6.59 | -136.0 | - | -14.81 |
| 2025-04-04 | FBRX | 6.00 | 76.3 | - | -3.68 |
| 2025-04-07 | FBRX | 5.75 | 76.3 | - | -3.60 |
| 2025-04-08 | FBRX | 5.56 | 76.3 | - | -3.60 |
| 2025-04-09 | FBRX | 5.92 | 76.3 | - | -3.60 |
| 2025-04-10 | FBRX | 5.60 | 76.3 | - | -3.60 |
| 2025-04-11 | FBRX | 5.25 | 76.3 | - | -3.60 |
| 2025-04-14 | FBRX | 5.59 | 76.3 | - | -3.60 |
| 2025-04-15 | FBRX | 5.84 | 76.3 | - | -3.60 |
| 2025-04-16 | FBRX | 7.01 | 76.3 | - | -3.60 |
| 2025-04-17 | FBRX | 7.34 | 76.3 | - | -3.60 |
| 2025-04-18 | FBRX | 7.34 | 76.3 | - | -3.60 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | FBRX | 1.87 | 4.46 | 0.24 |
| 2025-03-21 | FBRX | 1.87 | 4.46 | 0.24 |
| 2025-03-24 | FBRX | 1.87 | 4.46 | 0.24 |
| 2025-03-25 | FBRX | 1.87 | 4.46 | 0.24 |
| 2025-03-26 | FBRX | 1.87 | 4.46 | 0.26 |
| 2025-03-27 | FBRX | 1.87 | 4.46 | 0.26 |
| 2025-03-28 | FBRX | 1.87 | 4.46 | 0.26 |
| 2025-03-31 | FBRX | 1.87 | 4.46 | 0.26 |
| 2025-04-01 | FBRX | 1.87 | 4.46 | 0.26 |
| 2025-04-02 | FBRX | 1.82 | 4.46 | 0.26 |
| 2025-04-03 | FBRX | 1.82 | 4.46 | 0.26 |
| 2025-04-04 | FBRX | 1.82 | 4.46 | 0.26 |
| 2025-04-07 | FBRX | 1.82 | 4.46 | 0.26 |
| 2025-04-08 | FBRX | 1.82 | 4.46 | 0.26 |
| 2025-04-09 | FBRX | 1.82 | 4.46 | 0.26 |
| 2025-04-10 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-11 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-14 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-15 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-16 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-17 | FBRX | 1.82 | 4.46 | 2.22 |
| 2025-04-18 | FBRX | 1.82 | 4.46 | 2.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-2.74
Avg. EPS Est. Next Quarter
-1.11
Insider Transactions
1.82
Institutional Transactions
4.46
Beta
2.76
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
21
Sentiment Score
89
Actual DrawDown %
99.5
Max Drawdown 5-Year %
Target Price
49.33
P/E
Forward P/E
PEG
P/S
P/B
0.89
P/Free Cash Flow
EPS
-16.47
Average EPS Est. Cur. Y
-3.6
EPS Next Y. (Est.)
-2.25
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.47
Return on Equity vs Sector %
-87.6
Return on Equity vs Industry %
-74.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.04
EBIT Estimation
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 14
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading